[WESEE Medical] Nsws | Innovation Leads the Way: MicroVision Medical Ascends to New Heights
WESEE has been officially recognized as a National High-Tech Enterprise in December 2022, a milestone underscoring its outstanding
achievements in technological innovation and R&D capabilities.
As a leading innovator in the R&D, production, and sales of medical endoscopes, MicroVision Medical has adhered to its core philosophy of "
Technology-Driven Innovation, Quality First" since its inception. This national certification highlights the company’s excellence in technological R&D,
intellectual property management, product innovation, and scientific research capabilities.
Technology-Driven Excellence
By consistently increasing R&D investment, MicroVision Medical has built a robust innovation ecosystem with a highly skilled team. The company
has achieved breakthroughs in endoscope design, manufacturing, and clinical applications. This certification reflects both industry and governmental
recognition of its innovation capabilities and competitive edge.
A New Chapter of Growth
This certification not only elevates MicroVision Medical’s technical leadership but also unlocks new opportunities for global expansion. Guided by its ethos of "Innovation, Pragmatism, and Responsibility", the company will continue advancing medical technology to deliver superior products and
services worldwide.
